PPARD
Reactivité: Humain
WB, FACS
Hôte: Lapin
Polyclonal
RB31677
unconjugated
Indications d'application
ELISA (1:600000) Western Blot (1:500-1:5000) The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Format
Liquid
Buffer
In 20 mM KH2PO4, 150 mM NaCl, pH 7.2 (0.01 % sodium azide)
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Lee, Chawla, Urbiztondo, Liao, Boisvert, Evans, Curtiss: "Transcriptional repression of atherogenic inflammation: modulation by PPARdelta." dans: Science (New York, N.Y.), Vol. 302, Issue 5644, pp. 453-7, (2003) (PubMed).
Plutzky: "Medicine. PPARs as therapeutic targets: reverse cardiology?" dans: Science (New York, N.Y.), Vol. 302, Issue 5644, pp. 406-7, (2003) (PubMed).
Lazar: "Progress in cardiovascular biology: PPAR for the course." dans: Nature medicine, Vol. 7, Issue 1, pp. 23-4, (2001) (PubMed).
Chinetti, Fruchart, Staels: "Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation." dans: Inflammation research : official journal of the European Histamine Research Society ... [et al.], Vol. 49, Issue 10, pp. 497-505, (2001) (PubMed).